48 Biggest Movers From Yesterday
Gainers
Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share.
Technical Levels To Watch In Aytu BioPharma Stock
Aytu BioPharma Inc. (NASDAQ: AYTU) shares were rallying Monday after retail traders were able to push the stock higher.
31 Stocks Moving In Monday’s Mid-Day Session
Gainers
Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share.
21 Stocks Moving in Monday’s Pre-Market Session
Gainers
Raven Industries, Inc. (NASDAQ: RAVN) rose 47.2% to $56.86 in pre-market trading. CNH Industrial N.V
28 Stocks Moving in Friday’s Pre-Market Session
Gainers
Amesite Inc. (NASDAQ: AMST) rose 138% to $6.60 in pre-market trading after surging over 25% on Thursday.
Earnings Scheduled For May 17, 2021
Companies Reporting Before The Bell
• Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter.
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-the-board weakness in markets, as macroeconomic fears unnerved traders.
Aytu BioPharma Announces Publication Of In Vitro Study, Says Demonstrates That Ultraviolet-A Light Increases Mitochondrial Anti-Viral Signaling Protein Within Cells
Aytu BioPharma Announces Publication of In Vitro Study Demonstrating That Ultraviolet-A Light Increases Mitochondrial Anti-Viral Signaling Protein Within Cells
ENGLEWOOD, CO / ACCESSWIRE / May 12, 2021 / Aytu